
Zorway Exim Private Limited
About Zorway Exim Private Limited
Data last updated:
Zorway Exim Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U52399GJ2010PTC059829. Its GSTIN is 24AAACZ4265F1ZE (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjaykumar Jitendrabhai Jha and Ghanshyam Jitendrabhai Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 Malay Bunglows Opp. Mahalaya Bunglows Science City Road Sola, Ahmedabad, Gujarat, India – 380060.
As per the financials filed for FY 2025, the company reported a revenue of ₹77.35 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net loss of ₹40.46 Lakh (net margin -52.3%) and EBITDA of -₹35.11 Lakh (EBITDA margin -45.4%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 17% over five years.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zorway Exim Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address is in the company report.
- Email
- Registered Address21 Malay Bunglows Opp. Mahalaya Bunglows Science City Road Sola, Ahmedabad, Gujarat, India – 380060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zorway Exim Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zorway Exim is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zorway Exim Private Limited, buy the company report.
Financials of Zorway Exim Private Limited
FY 2025 filings availableZorway Exim Private Limited reported revenue of ₹77.35 Lakh (down 64% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 64% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹35.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹40.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -45.4% | ||||
| Net Profit Margin | -52.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zorway Exim Private Limited, buy the company report.
Board of directors of Zorway Exim Private Limited
Zorway Exim has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjaykumar Jitendrabhai Jha Also directs: Injexa Lifesciences Private Limited, Santis Pharmaceuticals Private Limited, Cuidado Medico Private Limited and 5 more | Director | 11 Mar 2010 | 16 Years 8 Months | Current |
| Ghanshyam Jitendrabhai Jha | Director | 11 Mar 2010 | 16 Years 8 Months | Current |
Peer comparison
Zorway Exim Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rashvi Bioscience Private Limited | ₹77.64 Lakh (FY 2024) | 5233.0% | Kadi, Gujarat, India | |||
| Pentawaves Trading Private Limited | ₹77.47 Lakh (FY 2025) | 6.0% | Thrissur, Kerala, India | |||
| Zorway Exim Private Limitedthis company | ₹77.35 Lakh (FY 2025) | -₹40.46 Lakh | -52.3% | -64.0% | Ahmedabad, Gujarat, India | |
| Nobitas Remedies Private Limited | ₹77.16 Lakh (FY 2025) | -8.0% | Jabalpur, Madhya Pradesh, India | |||
| Lifexa Mediglobe Private Limited | ₹77 Lakh (FY 2025) | -30.0% | Rajkot, Gujarat, India | |||
| Hiral Remedies Private Limited | ₹76.97 Lakh (FY 2024) | -6.0% | Kasipur, Uttarakhand, India |
To see the full peer comparison of Zorway Exim Private Limited, buy the company report.
Auditor
Zorway Exim Private Limited is audited by ASHVIN K YAGNIK & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHVIN K YAGNIK & CO | FY 2022 | 100710W |
Shareholding
The shareholding of Zorway Exim Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zorway Exim Private Limited, buy the company report.
Legal cases
Zorway Exim Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Malik Lifesciences Pvt Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case SC) | Filed against the company by an individual | Disposed |
To see the full case history of Zorway Exim Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zorway Exim Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zorway Exim has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACZ4265F1ZE | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zorway Exim Private Limited, buy the company report.
Recent activity
Zorway Exim Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Ghanshyam Jitendrabhai Jha was appointed as Director on 11 Mar 2010.
Frequently asked questions
Zorway Exim is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 March 2010 (16+ years old) and is registered under CIN U52399GJ2010PTC059829.
Zorway Exim has 2 current directors:
- Sanjaykumar Jitendrabhai Jha - Director
- Ghanshyam Jitendrabhai Jha - Director
The latest financial statements of Zorway Exim on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zorway Exim is 24AAACZ4265F1ZE, registered in Gujarat.
The CIN (Corporate Identification Number) of Zorway Exim is U52399GJ2010PTC059829. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zorway Exim has 2 court cases on record: 2 filed against it.
Zorway Exim was incorporated on 11 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Zorway Exim by revenue are Rashvi Bioscience Private Limited, Pentawaves Trading Private Limited, Nobitas Remedies Private Limited, Lifexa Mediglobe Private Limited, Hiral Remedies Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ghanshyam Jitendrabhai Jha was appointed as Director on 11 Mar 2010. Sanjaykumar Jitendrabhai Jha was appointed as Director on 11 Mar 2010.
The registered office of Zorway Exim is at 21 Malay Bunglows Opp. Mahalaya Bunglows Science City Road Sola, Ahmedabad, Gujarat, India – 380060.
Zorway Exim operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

